Influenza B Nucleoprotein antibody | B017 (B35G)
Filter by Application:WB IF Reset
Mouse anti Influenza B Nucleoprotein
- Product Type
- Monoclonal Antibody
- B017 (B35G)
- Influenza B Nucleoprotein
|Mouse anti Influenza B Nucleoprotein antibody, clone B017 recognizes an epitope within the nucleoprotein of influenza B virus.
The influenza viruses, classified as type A, B and C, are members of the Orthomyxoviridae family which differ in their epidemiology and host ranges and lack serological cross-reactivity of their internal components, especially their matrix proteins and nucleoprotein. Influenza B virus is a slow-mutating single stranded RNA virus subject to antigenic drift which, although enough to prevent lasting immunity, prevents influenza B from causing pandemics.
Mouse anti Influenza B Nucleoprotein antibody, clone B017 can be used in influenza B IFA typing in conjunction with MCA2717 (clone B114).
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography from tissue culture supernatant.
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- <0.1% Sodium Azide (NaN3)
- Influenza B/Lee/40 and B/Singapore/-222/79 viruses.
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Fusion Partners
- Spleen cells from immunized BALB/c mice were fused with cells of the P3 Ag8.653 mouse myeloma cell line.
- For research purposes only
- 12 months from date of despatch
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
|Application Name||Verified||Min Dilution||Max Dilution|
References for Influenza B Nucleoprotein antibody
Zhirnov, O.P. et al. (1999) Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells.
J Virol. 73 (12): 10158-63.
Ehrhardt, C. et al. (2007) Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses.
J Virol. 81 (21): 12097-100.
Dauber, B. et al. (2009) Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR.
PLoS Pathog. 5 (6): e1000473.
Goujon, C. & Malim, M.H. (2010) Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.
J Virol. 84 (18): 9254-66.
Lesch, M. et al. (2019) RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals
PLoS Pathog. 15(3):e1007601.
Walls, H.H. et al. (1986) Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses.
J Clin Microbiol. 23 (2): 240-5.
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.Yes, sign me up